330 related articles for article (PubMed ID: 15542810)
21. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
Baldus SE; Schaefer KL; Engers R; Hartleb D; Stoecklein NH; Gabbert HE
Clin Cancer Res; 2010 Feb; 16(3):790-9. PubMed ID: 20103678
[TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers.
Nosho K; Yamamoto H; Takahashi T; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Arimura Y; Itoh F; Imai K; Shinomura Y
Carcinogenesis; 2007 Jun; 28(6):1364-70. PubMed ID: 17183069
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
25. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
[TBL] [Abstract][Full Text] [Related]
26. [A new quantitative DNA-methylation analysis of MSI colorectal cancers helps to separate sporadic colorectal cancers from HNPCC-candidates].
Bettstetter M; Rümmele P; Hofstädter F; Dietmaier W
Verh Dtsch Ges Pathol; 2006; 90():236-43. PubMed ID: 17867602
[TBL] [Abstract][Full Text] [Related]
27. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD
Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414
[TBL] [Abstract][Full Text] [Related]
28. Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma.
Yagi K; Takahashi H; Akagi K; Matsusaka K; Seto Y; Aburatani H; Nakajima A; Kaneda A
Am J Pathol; 2012 Feb; 180(2):616-25. PubMed ID: 22115708
[TBL] [Abstract][Full Text] [Related]
29. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
Krol LC; 't Hart NA; Methorst N; Knol AJ; Prinsen C; Boers JE
Eur J Cancer; 2012 May; 48(7):1108-15. PubMed ID: 22446020
[TBL] [Abstract][Full Text] [Related]
30. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
[TBL] [Abstract][Full Text] [Related]
31. Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability.
Kominami K; Nagasaka T; Cullings HM; Hoshizima N; Sasamoto H; Young J; Leggett BA; Tanaka N; Matsubara N
J Int Med Res; 2009; 37(4):1038-45. PubMed ID: 19761686
[TBL] [Abstract][Full Text] [Related]
32. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
Fransén K; Klintenäs M; Osterström A; Dimberg J; Monstein HJ; Söderkvist P
Carcinogenesis; 2004 Apr; 25(4):527-33. PubMed ID: 14688025
[TBL] [Abstract][Full Text] [Related]
34. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
Wu M; Semba S; Oue N; Ikehara N; Yasui W; Yokozaki H
Gastric Cancer; 2004; 7(4):246-53. PubMed ID: 15616773
[TBL] [Abstract][Full Text] [Related]
35. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
Naghibalhossaini F; Hosseini HM; Mokarram P; Zamani M
Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633
[TBL] [Abstract][Full Text] [Related]
36. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
[TBL] [Abstract][Full Text] [Related]
37. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
Kim IJ; Kang HC; Jang SG; Kim K; Ahn SA; Yoon HJ; Yoon SN; Park JG
Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.
Knobbe CB; Reifenberger J; Reifenberger G
Acta Neuropathol; 2004 Dec; 108(6):467-70. PubMed ID: 15517309
[TBL] [Abstract][Full Text] [Related]
39. Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population.
Laskar RS; Talukdar FR; Choudhury JH; Singh SA; Kundu S; Dhar B; Mondal R; Ghosh SK
Tumour Biol; 2015 Jun; 36(6):4661-70. PubMed ID: 25647260
[TBL] [Abstract][Full Text] [Related]
40. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico.
Luévano-González A; Guzmán AQ; Ancer Rodríguez J; Ortiz López R; Rojas Martínez A; González Guerrero JF; Flores Gutiérrez JP
Arch Med Res; 2011 Aug; 42(6):457-62. PubMed ID: 21945875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
